XTRA:VOW3
XTRA:VOW3Auto

Is It Too Late to Consider VW After Its 32.5% Surge and EV Momentum?

Wondering if Volkswagen is still a value play after its recent run up, or if you are late to the party? Let us break down what the market is really pricing in and where the upside or downside might be hiding. Volkswagen's share price has climbed 5.6% over the last week, 13.4% over the past month, and is now up 22.3% year to date and 32.5% over the last year, which suggests investors are warming back up to the stock after a muted few years. Much of this momentum reflects renewed optimism...
XTRA:MBG
XTRA:MBGAuto

Is It Too Late to Consider Mercedes After Its Strong 2024 Share Price Run?

If you are wondering whether Mercedes-Benz Group is still a value play after its strong run, or if the easy money has already been made, you are in the right place to unpack what the market is really pricing in. The stock has climbed 3.1% over the last week, 4.7% over the last month, and is up 18.4% over the past year, with a hefty 75.1% gain over five years that suggests the market has gradually been warming to its story. Recently, investors have been reacting to the company sharpening its...
XTRA:HLAG
XTRA:HLAGShipping

Is Hapag-Lloyd (XTRA:HLAG) Quietly Mispriced? A Fresh Look at Its Valuation After Recent Share Price Stabilisation

Hapag-Lloyd (XTRA:HLAG) has been quietly grinding higher, with the stock up around 1% today and roughly 4% over the past week, even as year to date performance remains negative. See our latest analysis for Hapag-Lloyd. That recent pop in the share price looks more like the start of stabilising momentum than a full trend change. A modest 3 month share price return contrasts sharply with the weak year to date share price return and still solid 5 year total shareholder return. If Hapag-Lloyd has...
XTRA:AFX
XTRA:AFXMedical Equipment

Is Carl Zeiss Meditec’s (XTRA:AFX) Oncology Imaging Push Quietly Redefining Its Long‑Term Growth Story?

In November 2025, FluoGuide A/S announced a non-exclusive collaboration agreement with ZEISS Medical Technologies to advance FG001 for tumor imaging and surgical margin assessment in head and neck cancer, focused on supporting the clinical phase and with no initial payment or expected financial impact in 2025. This partnership underlines Carl Zeiss Meditec’s continued push into precision oncology imaging, where integrating advanced optics with novel tracers could broaden its long-term...
XTRA:TKMS
XTRA:TKMSAerospace & Defense

TKMS & Co KGaA (XTRA:TKMS): Evaluating Valuation After MDAX Inclusion and Record Defence Contract Wins

TKMS & Co KGaA (XTRA:TKMS) has been drawing fresh investor attention after its spin off from Thyssenkrupp, its rapid MDAX inclusion, a record order backlog and a string of big submarine contracts that have reshaped its growth story. See our latest analysis for TKMS & Co KGaA. Despite a cautious 2026 outlook, investors have leaned into the defence demand story, with a 7.79% 1 day share price return and 18.18% 7 day share price return hinting that momentum is building after a softer year to...
XTRA:BEI
XTRA:BEIPersonal Products

How Investors Are Reacting To Beiersdorf (XTRA:BEI) NIVEA’s ₦3bn Nigeria Real Madrid-Linked Reward Push

Earlier this month, Beiersdorf Nigeria launched NIVEA’s largest-ever consumer engagement campaign, a ₦3.00 billion reward program with cash prizes, SUVs, travel experiences and other benefits designed to deepen loyalty in a challenging macroeconomic backdrop. The promotion’s link to NIVEA’s extended five-year partnership with Real Madrid highlights how the brand is tying high-profile sports marketing to on-the-ground incentives in a key African growth market. We’ll now examine how this...
XTRA:SAP
XTRA:SAPSoftware

Assessing SAP (XTRA:SAP)’s Valuation After Its Recent Share Price Pullback

SAP (XTRA:SAP) has been drifting lower in recent months, and that pullback is starting to catch investor attention. With shares down double digits year to date, the key question is whether fundamentals still justify a fresh look. See our latest analysis for SAP. That slide in the share price, now around $210.1, comes after a strong multi year run. Recent weakness suggests momentum has cooled as investors reassess growth expectations and macro risk, even though the three year total shareholder...
XTRA:P4O
XTRA:P4OSemiconductor

3 European Penny Stocks With Market Caps Under €30M

As the European markets show mixed performance, with the pan-European STOXX Europe 600 Index edging higher on interest rate cut hopes, investors are increasingly exploring diverse opportunities within smaller market segments. Penny stocks, though often viewed as a relic of past trading days, continue to offer compelling prospects for those seeking growth at lower price points. These stocks typically represent smaller or newer companies and can provide significant value when backed by strong...